Newstral
Article
euobserver.com on 2021-05-05 07:04
[Ticker] Pfizer expects €22bn in vaccine sales this year
Related news
- Pfizer records $22bn COVID-19 vaccine sales in 2021punchng.com
- Pfizer expects $15bn sales of Covid-19 vaccineBBC
- [Ticker] BioNTech, Pfizer test 'universal' coronavirus vaccineeuobserver.com
- FPfizer halts China vaccine salesft.com
- Pfizer expects Covid vaccine demand for yearsBBC
- BPfizer Expects $26B in Covid-19 Vaccine Sales This Yearbarrons.com
- Pfizer expects $26 billion in 2021 sales from COVID vaccineNew York Post
- Vaccine sales power Pfizer through first quarterSeattle Times
- Pfizer expects $20b in COVID-19 vaccine revenue this yearSydney Morning Herald
- [Ticker] EU to assess Pfizer vaccine earlier than plannedeuobserver.com
- [Ticker] EMA to decide on Pfizer vaccine booster in Octobereuobserver.com
- [Ticker] EU approves extra corona-vaccine sites for Pfizer, Modernaeuobserver.com
- Pfizer hikes 2021 outlook after vaccine boosts sales, profittimesofisrael.com
- Pfizer to Cease Vaccine Sales Business in Chinawsj.com
- TPfizer posts narrower Q3 loss amid slumping Covid vaccine salesthestreet.com
- [Ticker] Russia-linked PR firm attacks Pfizer vaccine in Europeeuobserver.com
- EU approves Pfizer-BioNTech coronavirus vaccineThe Hindu
- Pfizer, BioNTech COVID vaccine wins European backingThe Fresno Bee